In this study, we report for the first time that EW-7197, a selective ALK5 inhibitor, blocks the production of TIMP-1 in TGF-β1-activated HSCs, which consequently interrupts communication between HSCs and HCC cells, and inhibits the progression and intrahepatic metastasis of HCC. Here, TGFBR1 is linked to hepatocellular carcinoma.